|
Richard W. Storrs, 42, is Vice President of Research at Cerco Medical. He received his B.A. in Chemistry from Amherst College in 1984 and a Ph.D. in Biophysical Chemistry from UC Berkeley in 1992. He was awarded an NRSA fellowship from the NIH for his work developing means for non-invasive detection of apoptosis, the process by which cells die in response to anoxia (such as in stroke or heart attack), chemotherapy, and immune rejection. He was a Scientist at DepoTech Corp., now SkyePharma, where he headed their hemostasis and anti-inflammatory programs. He is co-inventor of the sheet fabrication methods developed during pilot dog studies from 1998 to the present. | 